PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 184 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $6,745,000 | +9.1% | 148,913 | -8.3% | 0.50% | +6.5% |
Q3 2019 | $6,180,000 | -16.4% | 162,323 | -4.5% | 0.46% | -9.0% |
Q2 2019 | $7,390,000 | +7.5% | 169,926 | -5.9% | 0.51% | +16.9% |
Q1 2019 | $6,874,000 | -15.6% | 180,620 | -4.6% | 0.44% | -25.4% |
Q4 2018 | $8,143,000 | -17.9% | 189,283 | -6.2% | 0.59% | +6.9% |
Q3 2018 | $9,919,000 | +41.2% | 201,808 | -7.9% | 0.55% | +37.7% |
Q2 2018 | $7,026,000 | +0.8% | 219,220 | -2.1% | 0.40% | +2.8% |
Q1 2018 | $6,973,000 | -47.1% | 223,868 | -22.5% | 0.39% | -38.5% |
Q4 2017 | $13,188,000 | -2.2% | 288,887 | -19.5% | 0.63% | +14.8% |
Q3 2017 | $13,483,000 | -40.4% | 359,058 | -24.3% | 0.55% | -24.1% |
Q2 2017 | $22,625,000 | +2.4% | 474,309 | -2.1% | 0.72% | -2.7% |
Q1 2017 | $22,095,000 | +27.9% | 484,538 | -9.4% | 0.74% | +32.5% |
Q4 2016 | $17,278,000 | -30.1% | 534,924 | -25.9% | 0.56% | -12.6% |
Q3 2016 | $24,705,000 | +0.4% | 721,934 | -1.0% | 0.64% | +1.4% |
Q2 2016 | $24,606,000 | -70.1% | 729,493 | -53.0% | 0.63% | -40.2% |
Q1 2016 | $82,196,000 | +37.7% | 1,551,456 | +99.6% | 1.06% | -26.2% |
Q4 2015 | $59,697,000 | +84.0% | 777,411 | -1.5% | 1.43% | +85.0% |
Q3 2015 | $32,437,000 | +2.9% | 789,227 | +77.0% | 0.77% | +15.5% |
Q2 2015 | $31,532,000 | – | 445,861 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |